tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ACTU Stock Latest News

Craig-Hallum bullish on Actuate Therapeutics, initiates with a Buy
The FlyCraig-Hallum bullish on Actuate Therapeutics, initiates with a Buy
11d ago
ACTU
Actuate Therapeutics initiated with a Buy at Craig-Hallum
PremiumThe Fly
Actuate Therapeutics initiated with a Buy at Craig-Hallum
11d ago
ACTU
Actuate Therapeutics files to sell 3.9M shares of common stock for holders
PremiumThe Fly
Actuate Therapeutics files to sell 3.9M shares of common stock for holders
1M ago
ACTU
Actuate Therapeutics: Promising Phase 2 Results and Market Potential for Elraglusib in Metastatic Pancreatic Cancer
PremiumRatings
Actuate Therapeutics: Promising Phase 2 Results and Market Potential for Elraglusib in Metastatic Pancreatic Cancer
2M ago
ACTU
Actuate Therapeutics initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Actuate Therapeutics initiated with a Buy at H.C. Wainwright
2M ago
ACTU
Actuate Therapeutics completes enrollment in Phase 2 trial of elraglusib
PremiumThe FlyActuate Therapeutics completes enrollment in Phase 2 trial of elraglusib
2M ago
ACTU
Actuate Therapeutics announces EMA granted OMPD to elraglusib
Premium
The Fly
Actuate Therapeutics announces EMA granted OMPD to elraglusib
4M ago
ACTU
Actuate Therapeutics announces interim Phase 2 data of elraglusib
Premium
The Fly
Actuate Therapeutics announces interim Phase 2 data of elraglusib
5M ago
ACTU
Actuate Therapeutics announces new data from Phase 2 trial of elraglusib
PremiumThe Fly
Actuate Therapeutics announces new data from Phase 2 trial of elraglusib
5M ago
ACTU
Actuate Therapeutics added to Russell 2000 Index
PremiumThe Fly
Actuate Therapeutics added to Russell 2000 Index
5M ago
ACTU
Actuate announces FDA rare pediatric disease designation to elraglusib
PremiumThe Fly
Actuate announces FDA rare pediatric disease designation to elraglusib
6M ago
ACTU
Actuate Therapeutics announces publication on elraglusib’s mechanism of action
PremiumThe Fly
Actuate Therapeutics announces publication on elraglusib’s mechanism of action
7M ago
ACTU
Actuate announces data from safety cohort of Phase 2 trial of FOLFIRINOX
PremiumThe FlyActuate announces data from safety cohort of Phase 2 trial of FOLFIRINOX
8M ago
ACTU
Actuate Therapeutics announces U.S. FDA granted ODD for elraglusib
Premium
The Fly
Actuate Therapeutics announces U.S. FDA granted ODD for elraglusib
8M ago
ACTU
Actuate Therapeutics provides update on clinical trial of elraglusib
Premium
The Fly
Actuate Therapeutics provides update on clinical trial of elraglusib
8M ago
ACTU
Opening Day: Pheton, Powell Max make public debut
PremiumThe Fly
Opening Day: Pheton, Powell Max make public debut
8M ago
C
GS
Opening Day: Actuate Therapeutics makes public debut
PremiumThe Fly
Opening Day: Actuate Therapeutics makes public debut
9M ago
C
JPM
Actuate Therapeutics opens at $9.88, IPO priced at $8.00
PremiumThe Fly
Actuate Therapeutics opens at $9.88, IPO priced at $8.00
9M ago
ACTU

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >